相关实验视频
Updated: May 8, 2026

10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
14.2K
婴儿B组链球菌感染的复发:系统性审查
Francesca Miselli1,2, Alessandra Boncompagni1, Riccardo Cuoghi Costantini3
1Neonatal Intensive Care Unit, University Hospital of Modena, Modena, Italy.
Expert review of anti-infective therapy
|March 9, 2025
概括
乙组链球菌 (GBS) 感染可以在婴儿中复发,通常是在抗生素治疗后不久. 过早出生的婴儿最容易受到影响,长时间服用抗生素或停止母乳养可能无法防止GBS复发.
科学领域:
- 新生儿感染 新生儿感染
- 儿童传染病 儿童传染病
- 细菌病原发生的细菌.
背景情况:
- 乙组链球菌 (GBS) 是新生儿感染的主要原因.
- 抗生素治疗后侵袭性GBS疾病的复发很少见,但令人担忧.
- 关于婴儿GBS复发的流行病学,临床特征和结果的数据有限.
研究的目的:
- 调查在婴儿中复发的B组链球菌感染的流行病学,临床特征和结果.
- 确定GBS复发的风险因素和潜在的预防策略.
主要方法:
- 在PubMed和Embase进行了系统的文献搜索,截至2024年7月1日.
- 分析了患有复发性侵入性GBS感染的婴儿 (阳性血液和/或CSF培养物).
- 提取了人口统计,临床表现,治疗和结果的数据.
主要成果:
- 分析了146个单独的GBS复发病例,平均发生在治疗后10天.
- 大多数受影响的婴儿是早产 (63.5%) 并接受了足够的初始抗生素疗程.
- 血清型III占主导地位;GBS经常在母乳中检测到,在某些情况下,停止母乳养并不能防止进一步的复发. 病例死亡率为3.7%.
结论:
- 过早分娩与GBS复发密切相关.
- 适当的抗生素持续时间和停止母乳养不太可能防止GBS复发.
- 需要进一步的研究,以了解和预防易受伤害的婴儿GBS复发.
相关概念视频
Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

